The Wall Street Journal - "Guideline Experts Have Conflicts of Interest, Study Finds"

 – October 12, 2011 /Press Release/  –– 

The Institute of Medicine recommends that ideally, guideline developers shouldn’t have any financial investments in companies that stand to benefit from recommendations, nor should they (or family members) participate in marketing activities or advisory boards of those companies. Dr. Jennifer Neuman, an author of a study published in BMJ, and an instructor in the department of preventive medicine at Mount Sinai School of Medicine, says the concern is that panelists with financial ties to companies might give industry undue influence over guidelines. Learn more.